Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
about
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinCombined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.Overexpressed oncogenic tumor-self antigensCombined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.Cancer immunoprevention.Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response.Skin Allografting Activates Anti-tumor Immunity and Suppresses Growth of Colon Cancer in Mice.
P2860
Q28537820-3C06BBAE-874B-4088-9148-7BD9DDD60108Q33926200-9E068FCB-BBCA-495F-BF13-CC1602C7FA57Q34292741-6062D34D-A2C8-46CC-A3AD-29DF8032E699Q35107110-270BFF6E-C0AF-400D-81A2-DA473E830DB6Q35886756-19BEADEE-C623-4881-B022-EAABFE33723BQ35896426-37B1C744-4236-4E4A-BC3B-3AD3700317BCQ36723234-63B9DEFE-98AC-4F68-A96D-238DDBF2FF5CQ37368087-FED59FE8-6ACA-48B7-AA61-30AE60BC9B18Q39022359-8C2E58EB-AED0-4B70-9642-091E30FFB08FQ55717021-A302E46D-0623-45B4-A9CD-A99FAACFBB32
P2860
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
@en
type
label
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
@en
prefLabel
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
@en
P2093
P1476
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.
@en
P2093
Cornelis J Melief
Hans W Nijman
Ninke Leffers
Renee Vermeij
P304
P356
10.2174/138161212802002805
P50
P577
2012-01-01T00:00:00Z